Explore

Proviron (Mesterolone) Faces Strict Legal Restrictions and Health Risks in the U.S.

Proviron (Mesterolone) Faces Strict Legal Restrictions and Health Risks in the U.S.

Proviron, known generically as mesterolone, is a synthetic androgen with a chemical structure similar to dihydrotestosterone (DHT). While it has legitimate medical applications for conditions like low testosterone (hypogonadism), delayed puberty, and certain types of male infertility, its use is heavily regulated. In the United States, mesterolone is classified as a Schedule III anabolic steroid, making possession without a valid prescription a federal offense. It is not approved by the FDA for use in the U.S. The drug is also banned by the World Anti-Doping Agency (WADA) for athletes, with positive tests leading to multi-year bans, even with a prescription, unless a Therapeutic Use Exemption is granted. The prevalence of unprescribed use has led to significant concerns regarding its side effects and legal implications.

Testosterone Replacement Therapy (TRT) Aims to Restore Healthy Hormone Levels in Men with Clinically Low Testosterone

Testosterone Replacement Therapy (TRT) Aims to Restore Healthy Hormone Levels in Men with Clinically Low Testosterone

Testosterone Replacement Therapy (TRT) is a prescribed medical treatment designed to restore testosterone levels to a healthy physiological range in men diagnosed with clinically low testosterone. This therapy is available at facilities like Youth Lab Medical Spa in Summerville, South Carolina, and can be administered through various methods including pellets, topical creams, or injections. The dosage is customized based on individual lab results and symptoms, rather than a fixed protocol. TRT addresses symptoms commonly associated with declining testosterone, such as fatigue, reduced libido, decreased muscle mass, and brain fog. The primary objective of TRT is to replace deficient testosterone, not to elevate levels beyond the natural physiological range for enhancement purposes. Candidacy for TRT is determined by lab testing that confirms a clinical deficiency, alongside symptoms impacting daily life, and is not intended for individuals seeking to boost already normal testosterone levels for muscle build...

FDA Does Not Approve Nootropic Supplements Before Sale, Raising Safety Concerns

FDA Does Not Approve Nootropic Supplements Before Sale, Raising Safety Concerns

Nootropics, often marketed as 'smart pills' or cognitive enhancers, are substances consumed with the aim of improving memory, focus, or mental energy. These products encompass a range of items, including dietary supplements like caffeine, L-theanine, omega-3 fats, citicoline, bacopa monnieri, ginkgo biloba, and B vitamins. Additionally, some prescription medications, such as stimulants for ADHD or narcolepsy, are also considered nootropics when used under medical supervision. A critical aspect of the nootropics market in the U.S. is that dietary supplements are not subject to approval by the Food and Drug Administration (FDA) for safety and effectiveness before they are sold. This lack of pre-market regulation means that the quality, strength, and purity of these products can vary significantly between brands. The evidence supporting the effectiveness of many nootropic ingredients is often limited, with studies being small, short-term, or conducted on specific populations, making it difficult to generalize...

Cochrane Review Finds Pharmaceutical Marketing Negatively Influences Doctor Prescribing Habits

Cochrane Review Finds Pharmaceutical Marketing Negatively Influences Doctor Prescribing Habits

A new Cochrane review has concluded that pharmaceutical company marketing significantly influences doctors' prescribing habits, leading to more expensive, less appropriate, and increased drug prescriptions. The review analyzed 93 studies, with 88% originating from the United States, largely due to data availability from the Physician Payments Sunshine Act of 2010. Researchers categorized industry interactions into advertising and education, gifts and payments, and free samples. They found that advertising and education, such as sales representative visits, were linked to less clinically suitable and pricier prescriptions, often increasing prescription volume. Gifts and payments showed the most consistent evidence, correlating with less appropriate prescribing, higher prescription numbers, and increased costs. Dr. Lisa Bero of the University of Colorado Anschutz highlighted that these practices directly affect patient care, potentially leading to drugs with fewer benefits or more side-effects, or even unnec...

FDA Amends Food Standards to Allow Salt Substitutes in 139 Products

FDA Amends Food Standards to Allow Salt Substitutes in 139 Products

The U.S. Food and Drug Administration (FDA) has issued a final rule that permits the use of salt substitutes in 139 foods with existing standards of identity (SOI). Previously, these SOIs either required or allowed the addition of salt (sodium chloride) but did not explicitly permit the use of salt substitutes. This regulatory change is designed to provide food manufacturers with greater flexibility to reduce sodium content in their products. The FDA's action aligns with its broader multi-phase Voluntary Sodium Reduction Goals, which aim to encourage the food industry to gradually decrease sodium levels across the U.S. food supply. The amendment addresses a long-standing limitation where specific SOIs, which detail required and optional ingredients and sometimes production methods, restricted the use of alternatives to sodium chloride.

FDA Authorizes Microneedling for Specific Uses, Warns Against At-Home Devices and Unapproved Combinations

FDA Authorizes Microneedling for Specific Uses, Warns Against At-Home Devices and Unapproved Combinations

FDA Authorizes Microneedling for Specific Uses, Warns Against At-Home Devices and Unapproved Combinations

Maryland Lawmakers Consider Reforms as Independent Pharmacies Face Financial Crisis

Maryland Lawmakers Consider Reforms as Independent Pharmacies Face Financial Crisis

Maryland Lawmakers Consider Reforms as Independent Pharmacies Face Financial Crisis

FDA Updates Nationwide Eye Drop Recall Due to Sterility Concerns, Affecting Millions of Bottles

FDA Updates Nationwide Eye Drop Recall Due to Sterility Concerns, Affecting Millions of Bottles

The U.S. Food & Drug Administration (FDA) has updated a significant nationwide recall of eye drops, initially issued by Sterling Pharmaceutical Services LLC in August due to potential sterility concerns. On September 21, the FDA classified this as a Class II recall, indicating that using the affected products 'may cause temporary or medically reversible adverse health consequences.' While serious injury is deemed unlikely, consumers are advised to avoid using these drops. The recall impacts millions of bottles sold under various brand names, including those distributed to major drugstores and retailers across the country, such as Walgreens. The FDA's enforcement report provides a comprehensive list of affected products, including specific lot numbers and expiration dates for brands like AvKare, Reliable-1 Laboratories, Walgreens Lubricant Eye Drops, TRP The Relief Products, Major LubriFresh P.M. Nighttime Ointment, and Cameron Pharmaceuticals Lubricant Eye Drops. Consumers are urged to check their medicine...

Amazon-Brand Extra Strength Acetaminophen Recalled Over Consumer Complaints of Discolored Tablets

More than 112,000 bottles of Amazon-brand Extra Strength Acetaminophen have been voluntarily recalled following consumer complaints about discolored tablets. The U.S. Food and Drug Administration (FDA) published a report on October 2 detailing the recall, which was initiated on September 18 by Aurobindo Pharma USA Inc. The recall specifically targets 112,932 bottles of 500-milligram acetaminophen caplets that were sold through Amazon. The affected medication is available in 200-count, 500-count, and 1,000-count bottles. Consumers can identify the recalled products by specific lot numbers and expiration dates, which include: 200-count (Lot ACD125040A, Exp. Sept. 30, 2027), 500-count (Lots ACD124036A, ACD124030A, ACD124042A, ACD124048B, ACD125010A with various expiration dates), and 1,000-count (Lot ACD124048A, Exp. Nov. 30, 2027). The FDA has not yet assigned a classification indicating the level of health risk associated with this recall.

Frozen Pasta Product Recalled from Walmart Stores Due to Listeria Contamination Risk

Frozen Pasta Product Recalled from Walmart Stores Due to Listeria Contamination Risk

Over 1,000 cases of a frozen pasta product, Authentic Italian Lemon Alfredo Fettuccine, have been recalled due to potential Listeria contamination. The recall was initiated by Gias Foods of New York and affects products sold at Walmart stores nationwide, including in New York. Consumers can identify the recalled pasta by its yellow plastic packaging, UPC: 194346442706, lot numbers L6079C, L6080C, or L6081A, and expiration dates of September 19, 20, or 21, 2027. The U.S. Food and Drug Administration (FDA) advises consumers who have purchased this product to return it to the place of purchase for a full refund.

FDA Expands Frozen Berry Recall Due to E. Coli Contamination in Walmart and Trader Joe's Products

FDA Expands Frozen Berry Recall Due to E. Coli Contamination in Walmart and Trader Joe's Products

The U.S. Food and Drug Administration (FDA) has announced an expanded recall of frozen berries, including products sold at Walmart and Trader Joe's, due to potential contamination with E. Coli O145 bacteria. This expansion follows an initial recall in July involving Publix products and a subsequent expansion in September to include more Walmart items. The latest recall, announced on October 2, includes additional lots of Great Value frozen Organic Triple Berry Blend and Great Value frozen Organic Blueberries from Walmart, as well as one lot of Trader Joe’s frozen Organic Mixed Berry Blend. The contamination has been traced back to frozen blueberries from the July incident. The affected Walmart products were shipped to stores in 30 states and Puerto Rico, while the Trader Joe's products were distributed to select stores in 26 states and the District of Columbia. The broader outbreak has resulted in 17 reported illnesses and six hospitalizations, though these specific cases have not yet been linked to the mo...

US FDA approves Asahi Kasei's drug for persistent herpes infections

US FDA approves Asahi Kasei's drug for persistent herpes infections

Oct 9 (Reuters) - The US FDA on Friday approved Japan's Asahi Kasei's drug for persistent herpes simplex virus sores in certain patients with weakened immune systems who have not responded to available antiviral treatments.